Related Experiment Video

Updated: Apr 6, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

miR-137 inhibits proliferation of melanoma cells by targeting PAK2

Shuai Hao1, Chonglin Luo2, Alia Abukiwan2

  • 1Key Laboratory of Cell Proliferation and Regulation of Ministry of Education, Universities of the Confederated Institute for Proteomics, Beijing Normal University, Beijing, China.

Experimental Dermatology
|July 18, 2015
PubMed

Insights

MicroRNAs (miRNAs) like miR-137 suppress melanoma growth by targeting PAK2. This study used novel proteomics to confirm miR-137 downregulates PAK2, inhibiting cancer cell proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators in various cancers, including malignant melanoma.
  • miR-137 is recognized as a tumor suppressor in melanoma, with several validated targets.
  • Understanding miRNA-target interactions is vital for cancer therapy development.

Purpose of the Study:

  • To investigate the role of miR-137 in regulating melanoma cell proliferation.
  • To identify novel protein targets of miR-137 using advanced proteomics.
  • To elucidate the mechanism by which miR-137 affects melanoma progression.

Main Methods:

  • Utilized (35)S in vivo/vitro labelling analysis for dynamic proteomics (SiLAD) for sensitive protein expression rate analysis.
  • Employed bioinformatics analysis, luciferase reporter assays, and Western blot to validate miRNA-target interactions.
  • Performed cell proliferation assays and siRNA-mediated gene knockdown to assess functional impact.

Main Results:

  • SiLAD analysis revealed that miR-137 significantly downregulated the expression rate of p21-activated kinase 2 (PAK2) in melanoma cells.
  • PAK2 was confirmed as a direct target of miR-137 through multiple validation methods.
  • Overexpression of miR-137 inhibited melanoma cell proliferation, an effect mimicked by PAK2 knockdown.
  • Restoration of PAK2 levels reversed the miR-137-induced suppression of cell proliferation.

Conclusions:

  • miR-137 acts as a tumor suppressor in melanoma by targeting and downregulating PAK2 expression.
  • The miR-137/PAK2 axis represents a potential therapeutic target for melanoma treatment.
  • This study highlights the utility of SiLAD technology in uncovering miRNA functions.
Keywords:
melanomamiR-137microRNAproliferationproteomics

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K